The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Prevent Osteoporotic Fractures with a Fracture Liaison Service

Prevent Osteoporotic Fractures with a Fracture Liaison Service

May 18, 2019 • By Micah Yu, MD, Anna Lafian, DO, & Christina Downey, MD

  • Tweet
  • Email
Print-Friendly Version / Save PDF
alice-photo / shutterstock.com

alice-photo / shutterstock.com

Imagine leaving the hospital after suffering a heart attack without being treated for hypertension or being started on a beta blocker. What would we think of the hospital where patients are never educated about the relationship between treating hypertension and reducing myocardial infarction and stroke risk?

You Might Also Like
  • Osteoporotic Fracture Rates Similar with Denosumab, Alendronate in Real World
  • Baseline Bone Measures Predict Risk of Fragility Fracture in Postmenopausal
  • Hip Fractures Increasing in Older U.S. Women
Explore This Issue
May 2019

Unfortunately, this happens every day with osteoporosis and fractures in health systems around the world. Just as the link between untreated hypertension and myocardial infarction is undeniable, so is the knowledge that osteoporosis leads to fractures. Given its high prevalence, the potential for high costs passed on to patients and the health system overall, and the availability of drugs to treat and prevent fractures, osteoporosis should be considered an enormous public health concern.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

In the U.S. and Europe, it is estimated that approximately 30% of postmenopausal women have osteoporosis. Forty percent of these women will suffer at least one fragility fracture in their lifetime, and having an initial fragility fracture increases the risk of sustaining a new fracture by about 85%.1

Despite these astounding figures, diagnosis and treatment of osteoporosis remains low among physicians worldwide. As of 2016, the percentage of postmenopausal women being screened for osteoporosis in the U.S. was 41.9%, well below the national average for breast cancer screening (72.7%) and beta blocker treatment after a myocardial infarction (84.4%).2

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Even after patients are admitted and treated for non-traumatic fragility fractures, the osteoporosis management rate remains very low. One retrospective study found that treatment was prescribed in only 44% of cases after a vertebral fracture and only 21% of cases after a proximal femur fracture.3

Rheumatology Initiatives in Fracture Liaison Services

The abysmal rate of treatment after the sentinel event of first osteoporotic fracture makes this an area ripe for improvement. A Fracture Liaison Service (FLS) is a means to improve secondary prevention of osteoporotic fractures. The National Osteoporosis Foundation (NOF) recognizes the FLS as a means to improve outcomes related to secondary prevention of fractures.4

Geisinger Health System (GHS) was one of the first health systems to develop an FLS in the U.S. The GHS High Risk Osteoporosis Clinic was developed in 1996. It is a program headed by the Division of Rheumatology and uses osteoporosis management guidelines to help improve osteoporosis diagnosis and treatment.5 GHS was able to decrease hip fracture rates, increase the number of patients who receive a dual-energy X-ray absorptiometry (DXA) scan and increase the number of patients who received treatment.5

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Pages: 1 2 3 4 | Single Page

Filed Under: Conditions Tagged With: Fractures, Osteoporosis, osteoporosis treatments, osteoporotic fracture ratesIssue: May 2019

You Might Also Like:
  • Osteoporotic Fracture Rates Similar with Denosumab, Alendronate in Real World
  • Baseline Bone Measures Predict Risk of Fragility Fracture in Postmenopausal
  • Hip Fractures Increasing in Older U.S. Women
  • After Hip Fracture, Earlier Osteoporosis Drug Initiation Tied to Lower Subsequent Fracture Risk

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)